M
Marie Helene Baron
Publications - 4
Citations - 167
Marie Helene Baron is an academic researcher. The author has contributed to research in topics: Internal medicine & Adverse effect. The author has an hindex of 3, co-authored 4 publications receiving 150 citations.
Papers
More filters
Journal ArticleDOI
Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: Results of the French M-SFOP 98 protocol
Christian Carrie,Xavier Muracciole,Frederic Gomez,Jean-Louis Habrand,M Benhassel,Martine Mege,Marc Mahe,Philippe Quetin,Jean Philippe Maire,Françoise Soum,Marie Helene Baron,Pierre Clavere,Sophie Chapet,Zineb Gaci,H. Kolodie,Philippe Maingon,Bernard Vie,Valérie Bernier,Claire Alapetite,Sylvette Hoffstetter,Jacques Grill,Frederic Lafay +21 more
TL;DR: This hyperfractionated radiotherapy protocol with a reduced boost volume and without chemotherapy was not associated with early relapses in children, and intellectual function seemed to be preserved, which is promising.
Journal ArticleDOI
Online Quality Control, Hyperfractionated Radiotherapy Alone and Reduced Boost Volume for Standard Risk Medulloblastoma: Long-Term Results of MSFOP 98
Christian Carrie,Jacques Grill,Dominique Figarella-Branger,Valérie Bernier,Laetitia Padovani,Jean Louis Habrand,M Benhassel,Martine Mege,Marc Mahé,Philippe Quetin,Jean Philippe Maire,Marie Helene Baron,Pierre Clavere,Sophie Chapet,Philippe Maingon,Claire Alapetite,Line Claude,Anne Laprie,Sophie Dussart +18 more
TL;DR: HFRT protocol with conformal reduced boost and online quality control allows excellent long-term OS and EFS in the absence of chemotherapy, and FSIQ drops seem to be less pronounced than previously reported with standard irradiation regimens.
Journal ArticleDOI
Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy.
Bastiaan G Wortman,C. Post,Melanie E Powell,Pearly Khaw,Anthony Fyles,Romerai D'Amico,Christine Haie-Meder,Ina M. Jürgenliemk-Schulz,Mary McCormack,V. Do,Dionyssios Katsaros,Paul Bessette,Marie Helene Baron,Remi A. Nout,Karen Whitmarsh,Linda Mileshkin,Ludy C.H.W. Lutgens,Henry C Kitchener,Susan Brooks,Hans W. Nijman,Eleftheria Astreinidou,Hein Putter,Carien L. Creutzberg,Stephanie M. de Boer +23 more
TL;DR: In this article, the authors investigated whether IMRT, compared to 3DCRT, resulted in fewer adverse events (AEs) and patient-reported symptoms in the randomized PORTEC-3 trial for high-risk endometrial cancer.
Journal ArticleDOI
Quality assurance of a French multicentric conformal radiotherapy protocol for low-stage medulloblastoma : variability in target volume delineation
Xavier Muracciole,JC Cuilliere,Sylvette Hoffstetter,Claire Alapetite,Philippe Quetin,Marie Helene Baron,Z Gaci,J.-P. Maire,Sophie Chapet,Christian Carrie +9 more